Dr Denes is now with Spectrum pharmaceuticals researching BPH
Most recently, Dr. Denes served as the Director of Clinical Research with Lilly/ICOS, and was involved with the clinical development and launch of Cialis(R) (tadalafil). Prior to his tenure at Lilly/ICOS, Dr. Denes spent 23 years in clinical practice and as an Associate Professor of Urology at St. Louis University and served on many advisory boards. During this time, he gained broad experience in diseases of the prostate including BPH, prostate cancer, bladder cancer, overactive bladder and erectile dysfunction. Dr. Denes is Board Certified by the American Board of Urology and a member of the American College of Surgeons. Dr. Denes completed his medical school and residency training at Washington University in St. Louis
8 years 10 months ago - 8 years 10 months ago#33934by mmc
Here is a link to a site that has a whole series of interviews with Dr. Bela Denes (Urologist). I haven't looked up his credentials but when you go the the page you can what questions are asked/answered in each video in the series. I only watched a couple so far.
The ones I watched so far are called "Bladder Cancer prognosis" and "When to get checked for bladder cancer".
In the prognosis one they talk about things like differences in men's and women's bladders. Did you know women have thinner bladder walls than men? It also talks about women having 5-10% higher mortality rate and some reasons behind that. It also explains stages and grades and the like.
While I wouldn't consider this to be anything in depth, it seems like a reasonable high level overview and is addressed to lay people. I tend to like the nitty gritty doctor targeted material more but this seems like some reasonable educational material.
I have no idea how accurate the information is and some things seemed a bit too over-generalized to me, but it may be helpful to folks so I'm posting it here.